Abstract: Certain aspects of the present disclosure provide techniques for electric vehicle charging management. In one example, a method includes: building a graph representing an electrical topology of the electric vehicle charging facility and producing an updated graph by updating a state of the one or more network nodes based on electric current or power flow through the one or more passive electric components and updating a state of the one or more component nodes based on electric current or power produced or consumed by the one or more active electric components. The method further includes receiving a selected control strategy for the electric vehicle charging facility and adjusting an electric current or a power draw of an electric vehicle charging station in the electric vehicle charging facility based on the updated graph and the selected control strategy.

Abstract: A method includes automatically configuring a cluster using pre-defined templates of one or more servers positioned in an edge location. The method also includes creating a plurality of configuration profile templates. The method also includes obtaining one or more parameter values. The method also includes defining a plurality of parameters in each of the plurality of configuration profile templates based upon the one or more parameter values obtained. The method also includes creating a master template based on the plurality of configuration profile templates. The method also includes storing the master template in a repository. The method also includes automatically creating a planned inventory file based on the master template. The method also includes configuring the cluster of the one or more servers based on the planned inventory.

Abstract: A method includes identifying a master template from a repository corresponding to one or more servers in a preconfigured cluster positioned at an edge location. The identifying also includes receiving an input from a user defining a new configuration set by the user. The identifying also includes changing one or more parameter values in at least one configuration profile references. The identifying also includes creating a new master template based on the one or more parameter values. The identifying also includes creating a new planned inventory file based on the new master template. The identifying also includes changing an existing configuration of the one or more servers in the preconfigured cluster during runtime, based on the new planned inventory file.

Abstract: A method includes identifying a master template from a repository corresponding to one or more servers in a preconfigured cluster positioned at an edge location. The identifying also includes receiving an input from a user defining a new configuration set by the user. The identifying also includes changing one or more parameter values in at least one configuration profile references. The identifying also includes creating a new master template based on the one or more parameter values. The identifying also includes creating a new planned inventory file based on the new master template. The identifying also includes changing an existing configuration of the one or more servers in the preconfigured cluster during runtime, based on the new planned inventory file.

Abstract: Estimation of workforce skill gaps using social network services are described herein. An unfilled job is represented by a job posting on a social network service. A skill is predicted as being required for the unfilled job by determining that each member of a set of members has an electronic profile on the social network service listing the skill as possessed by the member. A quantity of unfilled jobs on the social network service requiring the predicted skill is calculated. A quantity of selected job-seeking members of the social network service is calculated, each selected job-seeking member having an electronic profile on the social network service listing the predicted skill as possessed by the selected job-seeking member. A workforce skill gap for the predicted skill is estimated by subtracting the calculated quantity of job-seeking members from the calculated quantity of unfilled jobs.

Abstract: Methods for treating diabetes mellitus and related conditions and symptoms are described. The methods are directed to administering a therapeutically effective amount of a compound. Compounds suitable for the invention include pyridoxal-5?-phosphate, pyridoxal, pyridoxamine, pyridoxine, a 3-acylated pyridoxal analogue, a pharmaceutically acceptable acid addition salt thereof, or a mixture thereof. Also disclosed are methods directed to concurrently administering a therapeutically effective amount of a compound with other compounds known in the treatment of diabetes mellitus. In one embodiment, a therapeutically effective amount of a compound is administered concurrently with a therapeutically effective amount of insulin. In another embodiment, a therapeutically effective amount of a compound is administered concurrently with a therapeutically effective amount of a hypoglycemic compound.

Abstract: The use of a food portion comprising dry and/or wet distiller's grain for preventing, treating or ameliorating cardiovascular pathologies is described.

Abstract: Methods for treating cardiovascular and related diseases such as hypertrophy are described. The methods are directed to concurrently administering a compound such as pyridoxal-5?-phosphate, pyridoxamine, pyridoxal, or a 3-acylated pyridoxal analogue with a therapeutic cardiovascular compound.

Abstract: Methods for treating cardiovascular and related diseases such as myocardial infarction are described. The methods are directed to concurrently administering a compound such as pyridoxal-5?-phosphate, pyridoxamine, pyridoxal, or a 3-acylated pyridoxal analogue with a therapeutic cardiovascular compound.

Abstract: Methods for treating cardiovascular and related diseases such as arrhythmia are described. The methods are directed to concurrently administering a compound such as pyridoxal-5?-phosphate, pyridoxamine, pyridoxal, or a 3-acylated pyridoxal analogue with a therapeutic cardiovascular compound.

Abstract: Methods for treating cardiovascular and related diseases such as blood clots are described. The methods are directed to concurrently administering a compound such as pyridoxal-5?-phosphate, pyridoxamine, pyridoxal, or a 3-acylated pyridoxal analogue with a therapeutic cardiovascular compound.

Abstract: Methods for treating cardiovascular and related diseases such as ischemia, ischemia reperfusion injuries, and myocardial ischemia, are described. The methods are directed to concurrently administering a compound such as pyridoxal-5?-phosphate, pyridoxamine, pyridoxal, or a 3-acylated pyridoxal analogue with a therapeutic cardiovascular compound.

Abstract: Methods for treating cardiovascular and related diseases such congestive heart failure are described. The methods are directed to concurrently administering a compound such as pyridoxal-5?-phosphate, pyridoxamine, pyridoxal, or a 3-acylated pyridoxal analogue with a therapeutic cardiovascular compound.

Abstract: A method of treating a cerebrovascular disease, particularly stroke, is described. A method of treating a cerebrovascular disease includes administering pyridoxal-5?-phosphate, pyridoxal, pyridoxine, pyridoxamine, 3-acylated analogues of pyridoxal, 3-acylated analogues of pyridoxal-4,5-aminal, pyridoxine phosphonate analogues, or pharmaceutical compositions thereof.

Abstract: Methods for treating diabetes mellitus and related conditions and symptoms are described. The methods are directed to administering a therapeutically effective amount of a compound. Compounds suitable for the invention include pyridoxal-5′-phosphate, pyridoxal, pyridoxamine, pyridoxine, a 3-acylated pyridoxal analogue, a pharmaceutically acceptable acid addition salt thereof, or a mixture thereof. Also disclosed are methods directed to concurrently administering a therapeutically effective amount of a compound with other compounds known in the treatment of diabetes mellitus. In one embodiment, a therapeutically effective amount of a compound is administered concurrently with a therapeutically effective amount of insulin. In another embodiment, a therapeutically effective amount of a compound is administered concurrently with a therapeutically effective amount of a hypoglycemic compound.

Abstract: The use of a food portion comprising dry and/or wet distiller's grain for preventing, treating or ameliorating cardiovascular pathologies is described.

Abstract: A method of treating a cerebrovascular disease, particularly stroke, is described. A method of treating a cerebrovascular disease includes administering pyridoxal-5′-phosphate, pyridoxal, pyridoxine, pyridoxamine, 3-acylated analogues of pyridoxal, 3-acylated analogues of pyriodoxal-4,5-animal, pyridoxine phosphonate analogues, or pharmaceutical compositions thereof.

Abstract: Methods for treating cardiovascular and related diseases such as hypertrophy are described. The methods are directed to concurrently administering a compound such as pyridoxal-5′-phosphate, pyridoxamine, pyridoxal, or a 3-acylated pyridoxal analogue with a therapeutic cardiovascular compound.

Abstract: Methods for treating cardiovascular and related diseases such as myocardial infarction are described. The methods are directed to concurrently administering a compound such as pyridoxal-5′-phosphate, pyridoxamine, pyridoxal, or a 3-acylated pyridoxal analogue with a therapeutic cardiovascular compound.

Abstract: Methods for treating cardiovascular and related diseases such congestive heart failure are described. The methods are directed to concurrently administering a compound such as pyridoxal-5′-phosphate, pyridoxamine, pyridoxal, or a 3-acylated pyridoxal analogue with a therapeutic cardiovascular compound.